1. |
Couzin J. Medicine. Bypassing medicine to treat diabetes[J]. Science, 2008, 320(5875):438-400.
|
2. |
Henquin JC, Ravier MA, Nenquin M, et al. Hierarchy of the beta-cell signals controlling insulin secretion[J]. Eur J ClinInvest, 2003, 33(9):742-750.
|
3. |
Wang Y, Liu J. Combination of bypassing stomach and vagus dissection in high-fat diet-induced obese rats—a long-term investigation[J]. Obes Surg, 2010, 20(3):375-379.
|
4. |
Irako T, Akamizu T, Hosoda H, et al. Ghrelin prevents development of diabetes at adult age in streptozotocin-treated newborn rats[J]. Diabetologia, 2006, 49(6):1264-1273.
|
5. |
Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach[J]. Nature, 1999, 402(6762):656-660.
|
6. |
Mclaughlin T, Abbasi F, Lamendola C, et al. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relativeto equally obese insulin-sensitive controls[J]. Clin Endocrinol Metab, 2004, 89(4):1630-1635.
|
7. |
Pöykkö SM, Kellokoski E, Hörkkö S, et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes[J]. Diabetes, 2003, 52(10):2546-2553.
|
8. |
趙乃倩, 余葉蓉, 譚惠文, 等. 大鼠胰腺離體灌注技術的建立 [J]. 中華內分泌代謝雜志, 2007, 23(5):459-463.
|
9. |
Broglio F, Arvat E, Benso A, et al. Ghrelin,a natural GH secretagogue produced by the stomach,induces hyperglycemia andreduces insulin secretion in humans[J]. J Clin Endocrinol Metab,.
|
10. |
Egido EM, Rodriguez-Gallardo J, Silvestre RA, et al. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion[J]. Eur J Endocrinol, 2002, 146(2):241-244.
|
11. |
Reimer MK, Pacini G, Ahrén B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse[J]. Endocrinology, 2003, 144(3):916-921.
|
12. |
Date Y, Nakazato M, Hashiguchi S, et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion[J]. Diabetes, 2002, 51(1):124-129.
|
13. |
Lee HM, Wang G, Englander EW, et al. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion:entericdistribution, ontogeny, influence of endocrine, and dietarymanipulations[J]. Endocrinology, 2002, 143(1):185-190.
|
14. |
Salehi A, Dornonville de la Cour C, Håkanson R, et al. Effects of ghrelin on insulin and glucagon secretion:a study of isolated pancreatic islets and intact mice[J]. Regul Pept, 2004, 118(3):143-150.
|
15. |
Chung H, Kim E, Lee DH, et al. Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation[J]. Endocrinology, 2007, 148(1):148-159.
|
16. |
Miao Y, Xia Q, Hou Z, et al. Ghrelin protects cortical neuron against focal ischemia/reperfusion in rats[J]. Biochem Biophys Res Commun, 2007, 359(3):795-800.
|
17. |
Thorens B, Wu YJ, Leahy JL, et al. The loss of GLUT2 expression by glucose-unresponsive beta cells of db/db mice is reversible and is induced by the diabetic environment[J]. J Clin Invest, 1992, 90(1):77-85.
|
18. |
Bell GI, Kayano T, Buse JB, et al. Molecular biology of mammalian glucose transporters[J]. Diabetes Care, 1990, 13(3):198-208.
|
19. |
Fukumoto H, Kayano T, Buse JB, et al. Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues[J]. J Biol Chem, 1989, 264(14):7776-7779.
|
20. |
Thorens B, Cheng ZQ, Brown D, et al. Liver glucose transporter:a basolateral protein in hepatocytes and intestine and kidney cells[J]. Am J Physiol Cell Physiol, 1990, 259(6 Pt 1):C279-C285.
|
21. |
Thorens B, Sarkar HK, Kaback HR, et al. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells[J]. Cell, 1988, 55(2):281-290.
|
22. |
Gould GW, Thomas HM, Jess TJ, et al. Expression of human glucose transporters in Xenopus oocytes:kinetic characterization and substrate specificities of the erythrocyte, liver, and brain isoforms[J]. Biochemistry, 1991, 30(21):5139-5145.
|
23. |
Orci L, Thorens B, Ravazzola M, et al. Localization of the pancreatic beta cell glucose transporter to specific plasma membrane domains[J]. Science, 1989, 245(4915):295-297.
|
24. |
Guillam MT, Hümmler E, Schaerer E, et al. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2[J]. Nat Genet, 1997, 17(3):327-330.
|
25. |
Guillam MT, Dupraz P, Thorens B. Glucose uptake,utilization,and signaling in GLUT2-null islets[J]. Diabetes, 2000, 49(9):1485-1491.
|
26. |
Guillemain G, Muñoz-Alonso MJ, Cassany A, et al. Karyopherin alpha2:a control step of glucose-sensitive gene expression in hepatic cells[J]. Biochem J, 2002, 364(Pt 1):201-209.
|
27. |
, 86(10):5083-5086.
|